Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Neurology|June 17, 2018
Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO studyCristina Tassorelli, Licia Grazzi, Marina de Tommaso, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|October 1, 2020
Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig studyClaudia Altamura, Sabina Cevoli, Cinzia Aurilia, et al.
Brain Sciences|July 27, 2024
Evaluating the Effectiveness, Tolerability, and Safety of Eptinezumab in High-Frequency and Chronic Migraine in Real World: EMBRACE-The First Italian Multicenter, Prospective, Real-Life StudyPiero Barbanti, Bianca Orlando, Gabriella Egeo, et al.
Antioxidants & Redox Signaling|October 9, 2014
Is SOD2 Ala16Val polymorphism associated with migraine with aura phenotype?Raffaele Palmirotta, Piero Barbanti, Maria Laura De Marchis, et al.
Cephalalgia : an International Journal of Headache|December 24, 2013
Comparison of frovatriptan plus dexketoprofen (25 mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: a randomized studyVincenzo Tullo, Fabio Valguarnera, Piero Barbanti, et al.
The Journal of Headache and Pain|May 2, 2015
Look beyond Catechol-O-Methyltransferase genotype for cathecolamines derangement in migraine: the BioBIM rs4818 and rs4680 polymorphisms studyMaria Laura De Marchis, Piero Barbanti, Raffaele Palmirotta, et al.
The New England Journal of Medicine|January 14, 2026
Fremanezumab in Children and Adolescents with Episodic MigraineAndrew D Hershey, Christina L Szperka, Piero Barbanti, et al.
Frontiers in Neurology|September 20, 2024
Improvement in diagnostic-therapeutic care pathways for women with migraine: an Italian Delphi panelSabina Cevoli, Piero Barbanti, Cinzia Finocchi, et al.
DNA and Cell Biology|December 11, 2014
Progesterone receptor gene (PROGINS) polymorphism correlates with late onset of migraineRaffaele Palmirotta, Piero Barbanti, Cristiano Ialongo, et al.
Journal of Neurology|February 11, 2024
Impact of multiple treatment cycles with anti-CGRP monoclonal antibodies on migraine course: focus on discontinuation periods. Insights from the multicenter, prospective, I-GRAINE studyPiero Barbanti, Cinzia Aurilia, Gabriella Egeo, et al.
Pageof 11